1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Hypercholesterolemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kulikov, VI; Muzya, GI | 1 |
| Holmes, A; Loscalzo, J; Willoughby, S | 1 |
| Granger, DN; Kimura, M; Kurose, I; Russell, J | 1 |
| Gerritsen, ME; Granger, DN; Horie, Y; Mori, N | 1 |
| Erl, W; Weber, C; Weber, KS; Weber, PC | 1 |
| Horie, M; Mase, T; Nagaoka, H; Sakurai, Y; Tomioka, K; Yamada, T | 1 |
| Gereliuk, IP; Stukal, IV | 1 |
2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hypercholesterolemia
| Article | Year |
|---|---|
Platelets and cardiovascular disease.
Topics: Blood Platelets; Cardiovascular Diseases; Diabetes Complications; Humans; Hypercholesterolemia; Hyperhomocysteinemia; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Primary Prevention; Risk Factors; Smoking | 2002 |
Effects of oxidized low density lipoprotein, lipid mediators and statins on vascular cell interactions.
Topics: Anticholesteremic Agents; Cell Adhesion; Cell Adhesion Molecules; Cell Line; Endothelium, Vascular; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Leukotriene B4; Lipoproteins, LDL; Monocytes; Platelet Activating Factor | 1999 |
5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hypercholesterolemia
| Article | Year |
|---|---|
Influence of platelet-activating factor, its cell analogs, and antagonist on the production of superoxide radicals by blood leukocytes of healthy and hypercholesterolemic individuals.
Topics: Animals; Cattle; Humans; Hypercholesterolemia; In Vitro Techniques; Leukocytes; Platelet Activating Factor; Reactive Oxygen Species; Superoxides | 2002 |
Effects of fluvastatin on leukocyte-endothelial cell adhesion in hypercholesterolemic rats.
Topics: Animals; Anticholesteremic Agents; Cell Adhesion; Cell Movement; Cholesterol, Dietary; Endothelium, Vascular; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Leukocytes; Leukotriene B4; Male; Platelet Activating Factor; Pravastatin; Rats; Rats, Sprague-Dawley | 1997 |
Ischemia-reperfusion induced microvascular responses in LDL-receptor -/- mice.
Topics: Animals; Antibodies, Monoclonal; Arteriosclerosis; Cell Adhesion; Hypercholesterolemia; Intercellular Adhesion Molecule-1; Leukocytes; Leukotrienes; Male; Mice; Mice, Knockout; Microcirculation; Myocardial Ischemia; Myocardial Reperfusion Injury; Platelet Activating Factor; Receptors, LDL; Serum Albumin | 1999 |
Effects of YM264, a novel PAF antagonist, on puromycin aminonucleoside-induced nephropathy in the rat.
Topics: Animals; Azepines; Disease Models, Animal; Glomerulonephritis, Membranous; Hypercholesterolemia; Male; Metabolic Clearance Rate; Methylprednisolone; Piperazines; Platelet Activating Factor; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidines; Ticlopidine; Triazoles | 1991 |
[Disorders of plasma lipid spectrum, lysoform levels of platelet activating factor and blood platelet sensitivity to adrenaline in patients with stable stress-induced stenocardia].
Topics: Adult; Angina Pectoris; Blood Platelets; Epinephrine; Humans; Hypercholesterolemia; In Vitro Techniques; Lipids; Lysophosphatidylcholines; Male; Middle Aged; Platelet Activating Factor; Psychophysiologic Disorders; Stress, Psychological | 1991 |